Abelardo Barez

Avila, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.

Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.

Journal: British journal of haematology

Published: February 26, 2026

Reply.

Reply.

Journal: The Journal of allergy and clinical immunology

Published: February 24, 2026

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation.

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 24, 2025

Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiency.

Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiency.

Journal: The Journal of allergy and clinical immunology

Published: May 13, 2025

Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus.

Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus.

Journal: Platelets

Published: May 14, 2024

Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting.

Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting.

Journal: HemaSphere

Published: October 26, 2023

Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.

Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.

Journal: Disease models & mechanisms

Published: April 04, 2023

Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.

Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.

Journal: Blood reviews

Published: March 23, 2023

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.

Journal: Cancers

Published: February 07, 2023

Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.

Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.

Journal: Infectious diseases and therapy

Published: November 02, 2022

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival.

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival.

Journal: British journal of haematology

Published: November 29, 2021

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 19, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026